The Jak-Stat signal transduction pathway is activated by many polypeptide ligands. The initial event leading to the signaling cascade is the binding of a ligand to its speci®c cell surface receptor. Two cytokine receptor families, class I and class II, are primarily utilized by ligands inducing the Jak-Stat pathway. These two families are characterized by their patterns of conserved amino acid residues within the receptor extracellular domains (Bazan, 1990; Thoreau et al., 1991) . The class I family has numerous members; cytokines utilizing these receptors activate a number of signal transduction pathways beside the Jak-Stat pathway. Whereas there are fewer class II family members, they are more speci®c in their choice of signal transduction pathways: so far, they tend to prefer Jak-Stat signaling over other pathways. Cytokine signaling through class II receptor complexes (Figure 1 ) is the subject of this review. Speci®cally, receptor complexes for type I and type II interferons (IFNs) and interleukin-10 (IL-10) and their ligand-induced signal transduction events will be brie¯y reviewed in this article. In addition, a distinct complex between coagulation factor VIIa (FVIIa) and tissue factor (TF), which belongs to the class II cytokine receptor family and may mediate signaling, will also be discussed. Other aspects of these receptors have also been recently reviewed (Domanski and Colamonici, 1996; Kirchhofer and Nemerson, 1996; Pestka et al., 1997a; Carmeliet and Collen, 1998; Mogensen et al., 1999) .
The class II cytokine receptor family consists of seven members with known function: tissue factor, three pairs of two receptor subunits of the receptor complexes for either type I (IFN-a, IFN-b, IFN-o, and IFN-t) and type II (IFN-g) IFNs and IL-10. In addition, there are currently two orphan receptors CRF2-8 and CRF2-9 (Kotenko and Pestka, unpublished data; Lok et al., 1999a,b) . The extracellular domains of the class II receptors have tandem ®bronectin type III (FNIII) domains. Most known family members have two tandem FNIII domains, although a subunit of the type I IFN receptor complex (IFN-aR1) has four tandem domains (Figure 2 ). The structures of the soluble extracellular domains of tissue factor and one subunit of the type II IFN receptor complex (IFN-gR1) have been determined (Harlos et al., 1994; Banner et al., 1996) . Their intracellular domains vary in length and do not demonstrate any similarity in their primary structures. Four receptor chains, IFN-aR1, IFN-aR2, IL-10R2 and IFN-gR2 are clustered on human chromosome 21 (Jung et al., 1987; Lutfalla et al., 1990 Lutfalla et al., , 1993 Lutfalla et al., , 1995 Langer et al., 1990; Soh et al., 1993 Soh et al., ,1994a Soh et al., ,1994b Reboul et al., 1999) . IFN-aRI has also been designated the a-chain (IFN-aRa) comparable to other cytokine receptor chains that bind ligand. It should be noted that for many receptor complexes, two or more chains can contribute to ligand-binding so that naming a ®rst ligand-binding component the a-chain may be fraught with erroneous implications. Furthermore, because the genetic nomenclature for human and mouse genes does not permit use of Greek letters, the designation of components with Greek letters immediately requires that the gene be designated by a dierent abbreviation than the protein. Thus, the recommended numerical nomenclature was derived with these notions in mind and provides abbreviations where the genes and the proteins use the same alliteration. For additional details of nomenclature see (Pestka et al., 1997a) . Two receptor chains, IFN-gR1 and CRF2-8, map to Chr. 6 (Rashidbaigi et al., 1986; Lok et al., 1999a) , two chains, TF and CRF2-9, are encoded on Chr. 1 (Carson et al., 1985; Lok et al., 1999b) and the IL-10R1 chain is encoded on Chr. 11 (Taniyama et al., 1995) . Members of the Jak family of tyrosine kinases associated with these receptors have been identi®ed in a Oncogene (2000) 19, 2557 ± 2565 ã 2000 Macmillan Publishers Ltd All rights reserved 0950 ± 9232/00 $15.00 www.nature.com/onc *Correspondence: S Pestka, Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, New Jersey, NJ 08901, USA number of studies and information about Stat recruitment sites is also summarized (Figure 1 and Table 1 ). The orphan receptor chains (CRF2-8 and CRF2-9) possess classical Stat3 recruitment sites (YXXQ) and likely a Jak1 association site (Stahl et al., 1995; Usacheva et al., 2000) .
Ligands utilizing class II cytokine receptors for signaling, namely IFNs and IL-10, are important immunomodulators able to induce a broad variety of biological responses depending on the cell type and speci®c conditions and/or additional costimulators. Type I IFNs, which include the family of IFN-as, IFN-b, and IFN-o, are initial vital signals for cells and the immune system to initiate an antiviral response. IFN-g and IL-10 are primarily involved in regulation of speci®c immune responses, promoting (driving toward) T H 1 or T H 2-like responses, respectively (see reviews Pestka et al., 1987 , Pestka, 1997b Moore et al., 1993) .
Both IFN-g and IL-10 are homodimers and their crystal structures have been reported (Ealick et al., 1991; Zdanov et al., 1995) . They have signi®cant homology in their tertiary structures despite the lack of signi®cant homology between their primary structures. Thus, it was not surprising that, when the receptor chains for these ligands were identi®ed, the structure of the functional IFN-g and IL-10 appeared to be similar although they utilize distinct receptor subunits for signaling ( Figures  3 and 4) and subsequently activate distinct but overlapping combinations of Jak and Stat proteins.
Although the crystal structure of only one ligandreceptor complex of this family of receptors, IFN-g and soluble IFN-gR1, has been reported (Walter et al., Figure 1 Class II cytokine receptor family. IL-10R1 and IL-10R2 are two subunits of the IL-10 receptor complexes (Lutfalla et al., 1993; Liu et al., 1994; Kotenko et al., 1997) . IFN-gR1 and IFN-gR2 are two subunits of the IFN-g receptor complex (Aguet et al., 1988; Soh et al., 1994a) . IFN-aR1 and IFN-aR2 are two subunits of the type I IFN receptor complex; IFN-aR2 has two membrane bound splice variants, IFN-aR2c with longer intracellular domain and IFN-aR2b with shorter intracellular domain Novick et al., 1994; Domanski et al., 1995; Lutfalla et al., 1995) . Only IFN-aR2c (IFN-aR2 shown in the Figure) is thought to be competent for Jak and Stat recruitment and signaling. Tissue factor (TF) is a receptor for coagulation factor VIIa (FVIIa) (Scarpati et al., 1987; Fisher et al., 1987; Spicer et al., 1987; Morrissey et al., 1987) . Orphan receptors CRF2-8 and CRF2-9 are also diagramed and the`?' means the ligand for them has not been identi®ed (Kotenko and Pestka, unpublished data; Lok et al., 1999a,b) . Jak members associated with the intracellular domains of the receptors and Stat members recruited directly or indirectly (in parentheses) through these receptors are shown. The dashes indicate these receptors do not recruit Stats or associated with Jaks. The`3?' and`Jak1?' means we predict that Stat3 and Jak1, respectively, recruited to the receptor chain based on the structure of the intracellular domain. Chromosomal locations of the receptors are also shown. The number of amino acid residues comprising the extracellular (signal peptide), transmembrane and intracellular domains of the receptors is shown for each of the receptor chains Receptor chains are as indicated in the legend for Figure 1 . Chromosomal locations of human receptor chains are shown. Jak members associated with the intracellular domains of the receptors and Stat members recruited directly or indirectly (in parentheses) through these receptors are shown. The dashes indicate the intracellular domains of these chains do not recruit Stats and/or Jaks, as noted in the Table. The`?' means the ligand has not been identi®ed; and`3?' and`Jak1?' means we predict that Stat3 and Jak1, respectively, recruited to the receptor chain based on the structure of the intracellular domain (Rashidbaigi et al., 1986; Jung et al., 1987 Jung et al., , 1988 Jung et al., , 1990 . The second chains (the IFN-gR2 or IL-10R2 chains, or R2 chains; also designated Rb chains) are required to assemble an active intracellular receptor complex and thus to initiate the signal transduction events (Figures 3 and 4) (Kotenko et al., 1995 (Kotenko et al., , 1996 . The intracellular domains of both the IFN-g and IL-10 R1 chains are associated with Jak1, whereas the second chains bring to their respective complexes distinct Jak family members associated with the R2 intracellular domains. The IFN-gR2 chain associates with Jak2 and the IL-10R2, with Tyk2. Ligand-induced oligomerization of receptor components results in Jak activation leading to phosphorylation of the R1 intracellular domains on Tyr residues. The functions of dierent Jaks in the various receptor complexes are not equivalent. For example, the Jak1 negative U4A cells expressing a kinase negative Jak1 mutant exhibit some activities in response to IFN-g, indicating that Jak1 predominantly plays a structural role in the IFN-g receptor complex rather than a catalytic role. In contrast, the Jak2 negative g2A cells expressing a kinase negative Jak2 mutant do not respond to IFN-g (Briscoe et al., 1996) . After the phosphorylation of the R1 intracellular domains occurs, Stats are then recruited to the receptor complexes based on speci®c interaction of Stat SH2 domains with appropriate phosphotyrosine motifs within the R1 intracellular domains. The R2 intracellular domains do not possess Stat recruitment or docking sites and thus do not participate in the Stat recruitment process. The Stats are then phosphorylated on Tyr residues resulting in homo-or heterodimer formation, dissociation from receptors and nuclear translocation. In the nucleus the Stat dimers bind to speci®c regions of promoters of cytokine-responsive genes and participate with other transcriptional factors, enhanceosomal and transcriptosomal proteins and other factors (Schaefer et al., 1995; Halle and Meisterernst, 1996; Bhattacharya et al., 1996; Zhang et al., 1996; Horvai et al., 1997; Carey, 1999; Gall et al., 1999; Pollack et al., 1999; Paulson et al., 1999; Nakashima et al., 1999; Zhang et al., 1999) . These complexes then modulate the ®nely-tuned and well-orchestrated transcription of cytokine-regulatable genes.
The combinations of Stats activated by IFN-g and IL-10 are distinct and in some aspects opposing. IFN-g triggers Stat1 and, in some cases, dependent on the cell type, speci®c conditions and/or ratio of receptor subunits expressed, a small amount of Stat3 (Shuai et al., 1992; Horvath et al., 1995; Sato et al., 1997; Caldenhoven et al., 1999; Kotenko et al., 1999) . In contrast, Stat3 and a small amount of Stat1 are activated during IL-10 signaling (Finbloom and Winestock, 1995; Wehinger et al., 1996; Kotenko et al., Kotenko et al., 1996 Kotenko et al., , 1997 Kotenko et al., , 1999 are then recruited to the complexes to initiate signal transduction events in the Jak-Stat pathway. Stats are recruited through the ligand binding chains (signal transducing receptors, Kotenko et al., 1996) . IFN-a (c) binding to the subunits of the type I IFN receptor complex, the IFN-aR2c and the IFN-aR1 chains, initiates the cascade of signal transduction events. All Stats involved in IFN-a signaling are activated through the intracellular domain of the IFN-aR2c chain . Signal transduction events activated upon binding of FVIIa (d) to TF are not well de®ned Figure 4 Model of the IFN-g and Epo receptor complexes. (a) represents the active heteromeric IFN-g receptor complex with two IFN-gR1 and two IFN-gR2 subunits per complex. The IFN-g homodimer binds to two IFN-gR1 chains, followed by its interaction with two IFN-gR2 chains. The association with receptor subunits Jak1 and Jak2 kinases (or other members of the Jak family substituting for Jak2) activate one another by transphosphorylation initiating the signaling cascade. JAS, represents Jak association site; SRS, Stat recruitment site; ST, signal transducing receptor; AC, accessory chain receptor; PTK, protein tyrosine kinase; gR2/X, chimeric receptor with the extracellular domain of the IFN-gR2 and the intracellular domains of various receptors swapped for the intracellular domain of the Hu-IFN-gR2 chain (Kotenko et al., 1996) . (b) represents the IFN-gR1 homodimer bound to IFN-g. The cytoplasmic domains of the two chains are too far apart to permit transactivation of the two Jak1 kinases. (c) depicts the EpoR/gR1 homodimer which, unlike the IFN-gR1 homodimer, permits transactivation of the two Jak1 molecules 1997). A single phosphotyrosine motif (YDKPH) within the IFN-gR1 chain is responsible for Stat1 recruitment (Greenlund et al., 1994) . Stat3 can be recruited to the tyrosine-phosphorylated IL-10R1 intracellular domain through the interaction with two Stat3 docking sites . Mechanisms of Stat3 activation by IFN-g as well as Stat1 activation by IL-10 have not been delineated. One possibility is that Stat1 or Stat3 can be activated in cells through activated Stat3 or Stat1, respectively; alternatively, the detection of the small amount of activated Stat1 by IL-10 or Stat3 by IFN-g does not occur in cells and might be an artifact of the EMSA.
In this context it is interesting to note that IFN-g and IL-10 act antagonistically, particularly in the regulation of T H 1 and T H 2 dependent immune responses; in addition, macrophage activation by IFN-g is inhibited by IL-10 ( Moore et al., 1993) . A number of mechanisms regulating this crosstalk can be proposed. It is possible that both cytokines use a similar approach to control T cells: the dierential expression of the IL-10 or IFN-g receptor second chains in T cell subsets, as already shown in the case of the IFN-gR2 chain (Pernis et al., 1995; Bach et al., 1995; Sakatsume and Finbloom, 1996; Novelli et al., 1996; Skrenta et al., 1996) . Alternatively, since Jak1 is activated by both ligands, if one of the R1 chains has a higher anity site for Jak1 binding than the other R1 chain, and if the amount of Jak1 is limited in a cell, then the two receptor complexes may compete for Jak1 recruitment required for a functional receptor complex. Another possible mechanism may occur at the level of Stat activation. The heterodimeric Stat1:Stat3 complex may have a higher association constant than the Stat1:Stat1 homodimeric complex. In this scenario Stat3 will sequester activated Stat1 and prevent formation of Stat1 homodimers. Thus, only when the level of activated Stat1 exceeds the level of activated Stat3, are Stat1 homodimers formed and able to initiate speci®c biological eects.
It is also likely that a minimal level of Stat1 activation is required to induce biological eects. This may explain our previous observations that, despite the fact that a small amount of Stat1 is activated by IL-10 or by modi®ed IFN-g receptor chains where the Stat1 recruitment site is substituted by a Stat3 recruitment site, the activation of Stat1 did not lead to activation of IFN-g speci®c biological activities .
Less is known about the structure of the IFN-a/b/o receptor complex. It is not certain whether type I IFNs interact with their receptor complex as monomers, dimers or trimers. It is likely that IFN-a interacts with the receptor as a monomer and IFN-b as a monomer or dimer (Pestka et al., 1983; Kempner and Pestka, 1986; Arduini et al., 1999) . Two subunits of the type I IFN receptor complex were identi®ed: Hu-IFN-aR1 and Hu-IFN-aR2 and its variants (Figures 1 and 3) . The major ligand binding chain is the Hu-IFN-aR2 chain (Novick et al., 1994; Domanski et al., 1995; Lutfalla et al., 1995; Cutrone and Langer, 1997) . This receptor chain is expressed as three variants resulting from dierential mRNA splicing. One, the Hu-IFNaR2a chain, is secreted, and the other two are membrane bound proteins with dierent lengths of their cytoplasmic domains: the IFN-aR2b chain with a shorter cytoplasmic domain than the IFN-aR2c chain. All these variant forms have the same extracellular domain and bind the ligands. However, only the IFNaR2c chain, which has the longer cytoplasmic domain, seems to function in signaling. The IFN-aR1 chain exhibits a distinct structural feature not present in other members of cytokine receptor class II family: its extracellular domain is twice the size of the extracellular domains of other members of this family, having four tandem FNIII domains rather than two. The IFN-aR1 chain binds most type I IFNs weakly at best, but modulates the dierential recognition of type I IFNs by the IFN-aR2/IFN-aR1 complex (Cutrone and Langer, 1997) . A soluble complex of human IFN-b with the extracellular domains of the IFN-aR1 and IFN-aR2 chains has an apparent stoichiometry of 1 : 1 : 1 (Arduini et al., 1999) . All type I IFNs activate Jak1 and Tyk2 tyrosine kinases during signal transduction leading to formation and activation of ISGF3 (IFN-a-Stimulated Gene Factor 3) DNA-binding complexes consisting of Stat1 and Stat2 transcriptional factors and p48 DNA-binding protein from the IFN regulatory factor (IRF) family of proteins (Fu et al., 1990 Schindler et al., 1992; Veals et al., 1992; Velazquez et al., 1992; MuÈ ller et al., 1993) . Jak1 is associated with the IFN-aR2c intracellular domain whereas the IFN-aR1 intracellular domain is associated with Tyk2 (Colamonici et al., 1994; Domanski et al., 1997) . Type I IFNs activate Stat1, Stat2 and Stat3 through the IFN-aR2c intracellular domain Nadeau et al., 1999) . The IFN-aR1 intracellular domain does not recruit Stats, but supports type I IFN signal transduction by bringing Tyk2 tyrosine kinase to the receptor complex. However, the IFN-aR1 intracellular domain can modulate type I IFN signaling: the deletion of amino acids 525 ± 544 of the IFN-aR1 intracellular domain created a receptor which produced an enhanced response (Gibbs et al., 1996) . These three receptor complexes de®ne a paradigm of signaling for cytokines utilizing class II cytokine receptors (Pestka et al., 1997a) . Ligand binding induces oligomerization of receptor subunits (Figures 3 and 4) . The receptor chains can be divided into two classes: (1) the actual Signal Transducers (ST), containing Stat (or other SH2 domain containing protein) Recruitment Sites (SRS) and Jak Association Sites (JAS); and (2) Accessory Chain (AC), containing only JAS, but no SRS. The higher anity ligand binding chains of the receptor complexes of the class II cytokine receptor family (IFN-gR1, IL-10R1 and IFN-aR2) are associated with Jak1 and, in addition, serve as the Stat recruitment chains. The primary function of the second chains of these receptors is to bring an additional tyrosine kinase to the receptor complexes, causing Jak cross-activation and initiation of signal transduction (Kotenko et al., 1995 (Kotenko et al., , 1996 Bach et al., 1996) . The second chains do not recruit Stats. The intracellular domains of the AC can be swapped with the intracellular domains of other receptors. These substitutions bring other Jaks to the receptor complexes without aecting signaling. Thus, the particular Jak kinase recruited to the AC does not provide speci®city for signal transduction (Figure 4) . Only their extracellular domains are speci®c for particular ligand receptor complexes. The Jaks show preferential speci®city for association with the receptor intracellular domains, but the kinases per se are promiscuous and interchangeable for the Jak-Stat signal transduction pathway (Kotenko et al., 1996 .
Within the cytokine class I receptor family there are cases where homodimerization of a single receptor chain appears sucient for signal transduction. In these instances, the receptor intracellular domain contains all the JAS and SRS regions necessary and sucient for signal transduction (as in the case of EpoR, GHR or ProR 2 ), the activation of a single Jak2 is observed and a separate accessory chain is not required (Argetsinger et al., 1993; Witthuhn et al., 1993; Campbell et al., 1994; DaSilva et al., 1994; David et al., 1994; Dusanter-Fourt et al., 1994; Rui et al., 1994) . However, the Epo-induced homodimerization of a chimeric protein with the EpoR extracellular domain and the IFN-gR1 intracellular domain (EpoR/gR1) was sucient for induction of IFN-g-like signaling ( Figure  4) (Muthukumaran et al., 1997) . In contrast, the ligand-induced homodimerization of appropriate R1 subunits of the native IFN-g and IL-10 receptor complexes without subsequent recruitment of R2 subunits does not cause initiation of a signal transduction cascade (Figure 4) . The explanation appears to come from the geometry of the receptor complexes. When the crystal structure of the IFN-g:IFN-gR1 complex was solved it became clear that, when one IFN-g homodimer binds two IFNgR1 molecules, the two receptor subunits do not interact with one another and are separated by 27A Ê at their closest point. Therefore, though the IFN-gR1 chain possesses both a Jak1 association site and a Stat1a-recruitment site, alone it is unable to transduce a signal on homodimerization as the two Jak1 kinases are not in physical proximity to permit transphosphorylation. In contrast, GH-or Epoinduced homodimerization of the GHR (de Vos et al., 1992) or the EpoR (Watowich et al., 1992) brings the intracellular domains of these receptors into close proximity allowing interaction of receptor-associated Jak2 molecules. Therefore, in the chimeric EpoR/gR1 dimer, two Jak1 kinases are brought suciently close together to activate one another, albeit ineciently (Figure 4) (Muthukumaran et al., 1997) .
Thus the cytokine class II receptor complexes possess a unique characteristic feature of the receptors relative to the positioning of the Jaks. The geometry of the receptor complexes is such that homodimerization of their R1 chains yields a non-functional intracellular receptor complex. The accessory R2 chain completes this function. We speculate that the presence of two distinct chains provides for more eective control and ®ne tuning of responses to ligand, and permits interactions with additional cellular components and, possibly, multiple pathways.
However, it seems likely that at least one member of the cytokine class II receptor superfamily does not follow the paradigm. Tissue factor, while a member of the class II cytokine receptor family, stands far apart from the receptor complexes for IFNs and IL-10. The crystal structure of the FVIIa:TF complex has been solved and is very dierent from that of the IFNg:IFN-gR1 complex Banner et al., 1996) . First, the residues within the TF extracellular domain interacting with the FVIIa are distinct from residues within the IFN-gR1 involved in interaction with IFN-g. Second, its ligand, the coagulation factor FVII, is a serine/threonine protease, a very unusual ligand for cytokine receptors. It does not demonstrate any structural similarity to either the IFNs or IL-10. Nevertheless, recent reports implicate induction of certain biological activities in cells after binding of FVIIa to TF, suggesting the existence of signal transduction events (Bromberg et al., 1995; Pendurthi et al., 1997; Ollivier et al., 1998; Poulsen et al., 1998; Cunningham et al., 1999; Camerer et al., 1999) . While, there is no data demonstrating direct activation of the Jak-Stat pathway by TF:FVIIa complex, cells transfected with a reporter gene under control of the IFN-ginducible promoter responded to FVIIa treatment by upregulation of reporter gene expression, although the authors suggested that MAP kinase activation was responsible for FVIIa-induced transcription of a reporter gene (Figure 3) (Poulsen et al., 1998) . It is not clear how this unusual couple TF:FVIIa evolved so far from the more classical cytokine class II ligand : receptor complexes. It is possible that TF plays role of the accessory chain, like R2 for the IL-10 or IFN-g receptor complexes or IFN-aR1 for the IFN-a receptor complex, but acquired the ability to bind its ligand FVIIa with high anity. However, the experiments with chimeric receptors do not demonstrate the ability of the TF intracellular domain to associate with Jaks (Kotenko and Pestka, unpublished data) . It remains to be seen whether the TF intracellular domain is responsible for initiation of signaling or whether there is an another yet unidenti®ed receptor subunit for FVIIa which transduces the signal alone or with the support of the TF intracellular domain. Two orphan class II receptors are possible candidates for an FVIIaR2 chain.
When studied in greater detail, the Jak-Stat pathway, originally discovered as a seemingly simple straightforward pathway (ligand:receptor pair ? Jaks ? distinct set of Stats ? speci®c biological eects), seems more and more complex with cross talk with other pathways. Numerous divergent interacting partners of Jaks and Stats have been discovered revealing or just suggesting many new, unpredictable functions for Jaks and Stats (KlingmuÈ ller et al., 1995; Marrero et al., 1995; Yamauchi et al., 1997; Guillet-Deniau et al., 1997; Pollack et al., 1999 Pollack et al., , 2000 . The Jak-Stat signal transduction pathway has evolved, likely together with cytokine families, from such lower eukaryotes as Dictyostelium discoideum (Adler et al., 1996; Kawata et al., 1997; Araki et al., 1998) . Along the evolutionary path, it acquired many new alternative functions but also retained at least partially, some original ancestral functions. Evolution from common ancestors may explain the fact that many cytokines activate an array of overlapping functions (Fambrough et al., 1999) . The speci®city of cytokine signaling developed during the expansion of the pathway has only started to be revealed. In spite of numerous elegant studies spotlighting certain aspects and mechanisms of the pathway, it seems likely that the Jak-Stat signaling network is still far from being completely elucidated.
Many directions remain to be explored in the area of cytokine class II receptors and signaling. Identi®cation of new receptors and their ligand partners (Kotenko and Pestka, unpublished data; Kotenko et al., 2000) and at least one unusual receptor:ligand pair (TF, FVIIa) requires a new perspective and, perhaps, some additional missing elements. The solution of the structure of several ligand:receptor signaling complexes should help to extend the existing paradigm for cytokine class II receptor complexes and signaling.
Abbreviations EpoR, Erythropoietin receptor; GHR, growth hormone receptor; ProR, prolactin receptor.
